Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence
Listen to this summary
The authors aimed to evaluate the effectiveness of Bulkamid™ injections for treating stress urinary incontinence (SUI) and mixed urinary incontinence (MUI), as well as to identify predictors for repeat injections and progression to sling surgery. Their findings indicate that Bulkamid™ significantly improves continence and quality of life, with a low rate of repeat procedures and sling conversions; however, younger age and the absence of general anesthesia were associated with higher rates of repeat injections. Overall, Bulkamid™ is presented as a safe and effective minimally invasive treatment option for women with SUI and MUI.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Neurourology and urodynamics
View all →May 8, 2026 · Neurourology and urodynamics
Effect of Intravesical Administration of Steroid Enemas on an Experimental Autoimmune Interstitial Cystitis-Like Mouse Model
May 8, 2026 · Neurourology and urodynamics
Factors Underlying Choice and Change of Absorbent Incontinence Products in Women With Urinary Incontinence
May 7, 2026 · Neurourology and urodynamics
Comment on "Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence"
Apr 28, 2026 · Neurourology and urodynamics
Satisfaction and Decisional Regret After Mesh Versus Non-Mesh Apical Pelvic Organ Prolapse Surgery
Apr 27, 2026 · Neurourology and urodynamics
Social Media as a Source of Information on Interstitial Cystitis/Bladder Pain Syndrome: Support Tool or Misinformation?
Apr 23, 2026 · Neurourology and urodynamics
Psychological and Psychiatric Issues in Functional Constipation, Fecal Incontinence and Bladder and Bowel Dysfunction-A Revised and Updated Document of the International Children's Continence Society (ICCS)
More in Urology
View all →May 10, 2026 · Lancet (London, England)
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 9, 2026 · Lancet (London, England)
The role of community-based blood pressure screening in improving hypertension care
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


